- Home
- BLTE vs UTG Comparison
BLTE vs UTG Comparison
Compare BLTE & UTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BLTE | UTG |
|---|---|---|
| Founded | 2018 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.3B |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | BLTE | UTG |
|---|---|---|
| Price | $158.00 | $36.65 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $156.00 | N/A |
| AVG Volume (30 Days) | 250.7K | ★ 317.8K |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.28% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 9.86 |
| Revenue | N/A | ★ $96,107,593.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.20 |
| Revenue Growth | N/A | ★ 8.35 |
| 52 Week Low | $49.00 | $25.26 |
| 52 Week High | $170.25 | $35.29 |
Technical Indicators
Market Signals| Indicator | BLTE | UTG |
|---|---|---|
| Relative Strength Index (RSI) | 56.72 | 45.63 |
| Support Level | $153.56 | $36.27 |
| Resistance Level | $170.25 | $37.39 |
| Average True Range (ATR) | 6.34 | 0.55 |
| MACD | -1.18 | 0.02 |
| Stochastic Oscillator | 28.64 | 45.34 |
Price Performance
Historical ComparisonAbout BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
About UTG Reaves Utility Income Fund of Beneficial Interest
Reaves Utility Income Fund is a closed-end management investment company. The company's investment objective is to provide a high level of after-tax income and total return consisting of tax-advantaged dividend income and capital appreciation. It invests a portion of its total assets in securities of utility companies, which may include companies in the electric, gas, water, telecommunications sectors, as well as other companies engaged in other infrastructure operations.